{"created_at":"Tue Feb 11 19:00:09 +0000 2014","id":433314531901972481,"id_str":"433314531901972481","text":"13F filed by Atlantic Investment Co http:\/\/t.co\/zFxbrntsd6 New Buys: $ABBV $SD   Sells: $CAT $ARP $PX $PVA","source":"\u003ca href=\"http:\/\/www.leapcrest.com\" rel=\"nofollow\"\u003eleapcrest\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":116856504,"id_str":"116856504","name":"Leapcrest ","screen_name":"leapcrest","location":"NYC","url":"http:\/\/specsituations.com","description":"Real time 13F reports - consolidated holdings, new buys & sells for every fund.  Follow @chensj for curated selection of value & activist funds","protected":false,"followers_count":22,"friends_count":1,"listed_count":1,"created_at":"Tue Feb 23 19:56:23 +0000 2010","favourites_count":0,"utc_offset":null,"time_zone":null,"geo_enabled":false,"verified":false,"statuses_count":854,"lang":"en","contributors_enabled":false,"is_translator":false,"is_translation_enabled":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/431225306725105664\/bp2Q_mHO_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/431225306725105664\/bp2Q_mHO_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/116856504\/1391953047","profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"symbols":[{"text":"ABBV","indices":[69,74]},{"text":"SD","indices":[75,78]},{"text":"CAT","indices":[88,92]},{"text":"ARP","indices":[93,97]},{"text":"PX","indices":[98,101]},{"text":"PVA","indices":[102,106]}],"urls":[{"url":"http:\/\/t.co\/zFxbrntsd6","expanded_url":"http:\/\/specsituations.com\/files\/13F-HR\/0001419345-20140211-102468940.pdf","display_url":"specsituations.com\/files\/13F-HR\/0\u2026","indices":[36,58]}],"user_mentions":[]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Mon Feb 10 23:15:52 +0000 2014","id":433016497254834176,"id_str":"433016497254834176","text":"RT @FierceBiotech: Gilead hands its hep C combo to the FDA as AbbVie race heats up. http:\/\/t.co\/sJnalAgC3u $GILD $ABBV","source":"\u003ca href=\"https:\/\/mobile.twitter.com\" rel=\"nofollow\"\u003eMobile Web (M5)\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":1478527765,"id_str":"1478527765","name":"Nafu Happ","screen_name":"NafuHap","location":"","url":null,"description":null,"protected":false,"followers_count":11,"friends_count":97,"listed_count":0,"created_at":"Mon Jun 03 00:21:38 +0000 2013","favourites_count":8,"utc_offset":-14400,"time_zone":"Atlantic Time (Canada)","geo_enabled":false,"verified":false,"statuses_count":208,"lang":"en","contributors_enabled":false,"is_translator":false,"is_translation_enabled":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/378800000550213933\/57a79caa78cd83d9b1ef9192730a854b_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/378800000550213933\/57a79caa78cd83d9b1ef9192730a854b_normal.jpeg","profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Mon Feb 10 22:15:47 +0000 2014","id":433001376784719873,"id_str":"433001376784719873","text":"Gilead hands its hep C combo to the FDA as AbbVie race heats up. http:\/\/t.co\/sJnalAgC3u $GILD $ABBV","source":"web","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":18294197,"id_str":"18294197","name":"FierceBiotech","screen_name":"FierceBiotech","location":"Washington, DC","url":"http:\/\/FierceBiotech.com","description":"Tweets by the Fierce Life Sciences editorial team. Get our daily biotech e-mail newsletter at http:\/\/FierceBiotech.com","protected":false,"followers_count":26686,"friends_count":472,"listed_count":983,"created_at":"Sun Dec 21 22:21:58 +0000 2008","favourites_count":3,"utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"verified":false,"statuses_count":13615,"lang":"en","contributors_enabled":false,"is_translator":false,"is_translation_enabled":false,"profile_background_color":"15184C","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/2579189363\/5zktggp40a8nfj341ed2_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/2579189363\/5zktggp40a8nfj341ed2_normal.jpeg","profile_link_color":"DB5E1F","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"EBEFC3","profile_text_color":"333333","profile_use_background_image":false,"default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":6,"favorite_count":1,"entities":{"hashtags":[],"symbols":[{"text":"GILD","indices":[88,93]},{"text":"ABBV","indices":[94,99]}],"urls":[{"url":"http:\/\/t.co\/sJnalAgC3u","expanded_url":"http:\/\/www.fiercebiotech.com\/story\/gilead-gets-its-hep-c-combo-fda-abbvie-race-heats\/2014-02-10","display_url":"fiercebiotech.com\/story\/gilead-g\u2026","indices":[65,87]}],"user_mentions":[]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"symbols":[{"text":"GILD","indices":[107,112]},{"text":"ABBV","indices":[113,118]}],"urls":[{"url":"http:\/\/t.co\/sJnalAgC3u","expanded_url":"http:\/\/www.fiercebiotech.com\/story\/gilead-gets-its-hep-c-combo-fda-abbvie-race-heats\/2014-02-10","display_url":"fiercebiotech.com\/story\/gilead-g\u2026","indices":[84,106]}],"user_mentions":[{"screen_name":"FierceBiotech","name":"FierceBiotech","id":18294197,"id_str":"18294197","indices":[3,17]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
